World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
15937
World Ranking
2595
National Ranking
1238

Overview

R. Paul Johnson is affiliated with Emory University in the United States and focuses on research in medicine with particular emphasis on immunology and microbiology. Their work spans multiple subfields including infectious diseases, immunology, virology, neurology, and public health, environmental and occupational health.

Their research centers on topics such as COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, immune cell function and interaction, HIV research and treatment, T-cell and B-cell immunology, interferon and immune responses, and the long-term effects of COVID-19.

Recent publications include the following:

  • Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection (2022, JCI Insight)
  • Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques (2023, Science Immunology)
  • Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques (2022, bioRxiv, Cold Spring Harbor Laboratory)
  • Postnatal Zika virus infection is associated with persistent abnormalities in brain structure, function, and behavior in infant macaques (2021, UNC Libraries)

They have frequently collaborated with researchers including Gregory K. Tharp, Elise G. Viox, Timothy N. Hoang, Amit A. Upadhyay, and Rayhane Nchioua.

Key publication venues for their work include:

  • JCI Insight
  • Science Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

Best Publications

  • Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection

    Ronald S. Veazey;Mary Ann DeMaria;Laura V. Chalifoux;Daniel E. Shvetz

  • Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

    M. A. Goodell;M. Rosenzweig;Hyung Kim;D. F. Marks

  • Endogenous Bacterial Endophthalmitis: Report of a Ten-year Retrospective Study

    Annabelle A. Okada;R. Paul Johnson;W. Conrad Liles;Donald J. D'Amico

  • Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.

    H L Robinson;D C Montefiori;R P Johnson;K H Manson

  • Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection

    Thomas Harrer;Ellen Harrer;Spyros A. Kalams;Tarek Elbeik

  • Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

    O O Yang;S A Kalams;A Trocha;H Cao

  • Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus

    Ronald C. Desrosiers;Jeffrey D. Lifson;James S. Gibbs;Susan C. Czajak

  • Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge

    Michael S. Wyand;Kelledy Manson;David C. Montefiori;Jeffrey D. Lifson

  • Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.

    Satoshi Ishido;Joong-Kook Choi;Bok-Soo Lee;Chunyang Wang

  • A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus.

    R C Desrosiers;V G Sasseville;S C Czajak;X Zhang

  • Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

    O O Yang;S A Kalams;M Rosenzweig;A Trocha

  • Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

    R. Paul Johnson;Jeffrey D. Lifson;Susan C. Czajak;Kelly Stefano Cole

  • An Animal Model for Acute and Persistent Epstein-Barr Virus Infection

    Amir Moghaddam;Michael Rosenzweig;David Lee-Parritz;Bethany Annis

  • Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques

    A Kaur;R M Grant;R E Means;H McClure

  • Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

    R P Johnson;R L Glickman;J Q Yang;A Kaur

  • Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

    C Brander;K E Hartman;A K Trocha;N G Jones

  • Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells

    Michael Rosenzweig;Michelle Connole;Rhona Glickman;Soon-Pak Shinji Yue

  • Protective immunity induced by live attenuated simian immunodeficiency virus

    R Paul Johnson;Ronald C Desrosiers

  • Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

    O O Yang;A C Tran;S A Kalams;R P Johnson

  • Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.

    Patrick L. Collins;Marina Cella;Sofia I. Porter;Shasha Li

  • Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques

    Jörn E. Schmitz;R. Paul Johnson;Harold M. McClure;Kelledy H. Manson

  • Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus

    Cynthia G. Murphy;William T. Lucas;Robert E. Means;Susan Czajak

Frequent Co-Authors

Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Jeffrey D. Lifson
Jeffrey D. Lifson Leidos (United States)
Michael Piatak
Michael Piatak Leidos (United States)
Ashley T. Haase
Ashley T. Haase University of Minnesota
Keith G. Mansfield
Keith G. Mansfield Novartis (Switzerland)
Bruce D. Walker
Bruce D. Walker Harvard University
David C. Montefiori
David C. Montefiori Duke University
Mark B. Feinberg
Mark B. Feinberg International AIDS Vaccine Initiative
David I. Watkins
David I. Watkins George Washington University
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career opportunities within healthcare and research. Many aspiring professionals consider pursuing a doctorate in nursing salary programs, which offer advanced practice knowledge and competitive compensation across various states.

Nurses looking to specialize can transition smoothly from an FNP (Family Nurse Practitioner) to an acute care role. Resources on how to effectively make this shift are invaluable, such as guides detailing the fnp to acnp journey. Understanding these pathways helps tailor your career toward specialized patient care in acute settings.

Accelerated options exist for those with a strong foundational background who want to become nurse practitioners quickly. Many prefer enrolling in an accelerated np program that balances flexibility with comprehensive clinical training.

For individuals without a nursing background but interested in healthcare roles related to immunology, there are several online nursing programs for non nurses. These pathways provide the necessary education to enter the nursing field and contribute meaningfully to immunology-focused clinical practice and research.

Best Scientists Citing R. Paul Johnson

Trending Scientists